Keyphrases
Anovulatory Infertility
11%
Atypical Hemolytic Uremic Syndrome (aHUS)
23%
Beverage Consumption
23%
Caffeinated Beverages
11%
Cervical Cancer Patients
23%
Commonly Consumed
11%
Dietary Choices
11%
Early Discharge
47%
Elderly Patients
33%
Elderly Women
23%
Endometrial Cancer
15%
Endometriosis
11%
ErbB2
7%
External Beam Radiotherapy
23%
Fibroids
47%
Fluorescence in Situ Hybridization
7%
Green Tea
23%
Gynaecological Pathology
23%
Gynecologic Surgery
30%
Her2neu
7%
Hysterectomy
23%
Interventional Radiology
15%
Minimally Invasive Gynecologic Surgery
47%
Minimally Invasive Surgery
16%
Molecular Sequencing
23%
Myomectomy
23%
Node-positive
23%
Older Women
12%
Patient Experience
23%
Physical Intelligence
11%
Plethora
11%
Polycystic Ovary Syndrome
11%
Postoperative Outcomes
11%
Primary Dysmenorrhea
11%
Protective Effect
11%
Referral Management
23%
Referral Patterns
23%
Retrospective Cohort Study
30%
Robotic-assisted
23%
Serous Adenocarcinoma
23%
Super-elderly
23%
Sweetened Beverages
11%
Symptomatic Uterine Fibroids
10%
Therapeutic Target
23%
Treatment Options
11%
Tumor
7%
Uterine Artery Embolization
10%
Uterine Fibroids
23%
Uterine Serous
23%
Uterus
11%
Medicine and Dentistry
Adenocarcinoma
23%
Atypical Hemolytic Uremic Syndrome
23%
Cervical Cancer
23%
Chemotherapy Regimens
7%
Combination Therapy
9%
Consultation
43%
Disease
7%
Dysmenorrhea
11%
Elderly Patient
37%
Endometrial Cancer
15%
Endometriosis
11%
External Beam Radiotherapy
23%
Fluorescence in Situ Hybridization
7%
Gynecological Surgery
100%
Hysterectomy
23%
Immunohistochemistry
7%
Interventional Radiologist
5%
Interventional Radiology
15%
Medicine
11%
Minimally Invasive Surgery
23%
Multivariate Analysis
6%
Neoplasm
7%
Oncologist
6%
Oral Contraceptive
5%
Patient Care
5%
Patient Experience
23%
Patient Referral
23%
Polycystic Ovary Syndrome
11%
Postoperative Complication
14%
Recurrent Disease
7%
Retrospective Cohort Study
31%
Shared Decision Making
5%
Surgeon
29%
Surgery
9%
Surgical Approach
8%
Telemedicine
5%
Trastuzumab
7%
Uterine Artery Embolization
13%
Uterine Fibroid
23%
Uterine Myomectomy
23%